The crystal structure of arabinose-5-phosphate isomerase (API) from Bacteroides fragilis (bfAPI) was determined at 1.7 Å resolution and was found to be a tetramer of a singledomain sugar isomerase (SIS) with an endogenous ligand, CMP-Kdo (cytidine 5 0 -monophosphate-3-deoxy-d-mannooct-2-ulosonate), bound at the active site. API catalyzes the reversible isomerization of d-ribulose 5-phosphate to d-arabinose 5-phosphate in the first step of the Kdo biosynthetic pathway. Interestingly, the bound CMP-Kdo is neither the substrate nor the product of the reaction catalyzed by API, but corresponds to the end product in the Kdo biosynthetic pathway and presumably acts as a feedback inhibitor for bfAPI. The active site of each monomer is located in a surface cleft at the tetramer interface between three monomers and consists of His79 and His186 from two different adjacent monomers and a Ser/Thr-rich region, all of which are highly conserved across APIs. Structure and sequence analyses indicate that His79 and His186 may play important catalytic roles in the isomerization reaction. CMPKdo mimetics could therefore serve as potent and specific inhibitors of API and provide broad protection against many different bacterial infections.
Introduction
Gram-negative bacteria are distinguished from Gram-positive bacteria by having an extra outer membrane outside their cell wall. This outer membrane serves as a permeability barrier for foreign molecules, thus making Gram-negative bacteria generally more resistant to antibiotics. Certain pathogenic Gram-negative bacteria, such as Salmonella, Yersinia pestis, Klebsiella and certain strains of Escherichia coli, are responsible for serious outbreaks and occurrences of infectious diseases throughout the world. Antibiotic treatment alone is often not sufficient to combat these infections, and several antibiotic-resistant strains of Enterobacteriaceae have emerged where no effective drugs are currently available for treatment.
The bacterial outer membrane is an asymmetric glycerophospholipid bilayer with lipopolysaccharides (LPS) located exclusively in the outer layer. These LPS typically consist of three distinct regions: lipid A, a core oligosaccharide and an O-antigen polysaccharide (Cipolla et al., 2009) . Lipid A, the hydrophobic portion of LPS, is a glucosamine-based phospholipid. The recognition of LPS by the human immune system and the subsequent immune response to Gramnegative infection is typically attributed to lipid A. The core oligosaccharide can be divided into inner and outer oligosaccharide cores. The inner oligosaccharide core directly attaches to lipid A and is primarily made of 3-deoxy-d-mannooct-2-ulosonate (Kdo) moieties, which together with lipid A constitute the most conserved component of LPS. In Gramnegative bacteria, Kdo is essential for outer membrane biogenesis and cell viability. The minimal LPS structure required for the growth of E. coli consists of two Kdo modules attached to lipid A (Kdo 2 -lipid A; Raetz & Whitfield, 2002) . The biosynthesis of Kdo involves four sequential steps. Arabinose-5-phosphate isomerase (API) catalyzes the reversible keto-aldol isomerization of the pentose pathway intermediate d-ribulose 5-phosphate (Ru5P) to d-arabinose 5-phosphate (A5P) in the first step of Kdo biosynthesis (Fig. 1a) . APIs are highly conserved among Gram-negative bacteria and are often the only de novo source of A5P, which is not available via glycolysis. Therefore, API is potentially an ideal target for the development of Gram-negative antibacterial drugs, and a potent inhibitor could offer broad protection against many different bacterial infections.
APIs exist either as single-domain sugar isomerase (SIS) proteins or multi-domain proteins consisting of an SIS domain and one or two tandem cystathionine--synthase (CBS) domains. The SIS domain is commonly found in keto-aldol sugar isomerases and other proteins that regulate the expression of genes involved in phosphosugar biosynthesis. CBS domains are found in a variety of proteins and play regulatory roles, although their exact function is unknown. API is abundant in Gram-negative bacteria, and some bacteria even contain multiple paralogs. For example, the uropathogenic E. coli CFT073 (O6:K2:H1) strain contains four API paralogs: KdsD, KpsF (Meredith & Woodard, 2006) , GutQ (Meredith & Woodard, 2005) and c3406 (Mosberg et al., 2011) . Although all of these APIs catalyze the same chemical reaction, they are involved in different specific biological functions. KdsD is involved in LPS biosynthesis. KpsF is encoded within the kps (capsular polysaccharide) gene cluster and is involved in capsule formation. The gutQ gene, on the other hand, is located in an operon involved in d-glucitol (sorbitol) metabolism. However, the involvement of GutQ in the metabolism of d-glucitol, or a link between d-glucitol metabolism and LPS biosynthesis, has not been established (Meredith & Woodard, 2005; Cech et al., 2014) . The biological significance of the API redundancy in E. coli is currently unknown, but it is speculated that they may have additional roles besides producing A5P.
In order to explore the structure and function of API, we have determined the crystal structure of arabinose-5-phosphate isomerase from Bacteroides The Kdo biosynthetic pathway, substrate analogues and inhibitors. (a) The Kdo biosynthetic pathway. The enzymes involved are (1) arabinose-5-phosphate isomerase (API), (2) Kdo-8-phosphate (Kdo-8-P) synthase, (3) Kdo-8-P phosphatase and (4) cytidine 5 0 -monophosphate-Kdo synthetase. API catalyzes the reversible isomerization of d-ribulose 5-phosphate (Ru5P) to d-arabinose 5-phosphate (A5P) in the first step of Kdo biosynthesis. E. coli contains multiple paralogs of API genes including kdsD, kpsF and gutQ. The open-chain form and the ring form of A5P and Kdo-8-P are shown. PEP stands for phosphoenolpyruvate. The C1 and C2 atoms of A5P are marked with red asterisks. The C4 and C5 atoms of CMP-Kdo derived from C1 and C2 of A5P are also marked with red asterisks. (b) 5-Phospho-darabinonate (5PAA), a G6P substrate analog commonly used in enzyme mechanistic studies of PGI, is shown on the left. 4-Phospho-2,3-acetyl-d-erythrose hydroxamate (4PEH) was the most potent API inhibitor among the hydroxamate compounds tested in a study of F. tularensis KdsD .
fragilis NCTC 9343 (bfAPI) at 1.7 Å resolution. bfAPI is a single-domain SIS protein with an endogenous CMP-Kdo molecule bound at the active site. Interestingly, CMP-Kdo is neither the substrate nor the product of the reaction catalyzed by API, but corresponds to the end product of the Kdo biosynthetic pathway; it could therefore act as a feedback inhibitor. Our conclusions are supported by a recent study that demonstrates that bfAPI has arabinose-5-phosphate isomerase activity and is inhibited by CMP-Kdo (Cech et al., 2014) . Here, we report the structural analysis of bfAPI and its functional implications. The crystal structure was determined using the semi-automated high-throughput pipeline of the Joint Center for Structural Genomics (JCSG; Lesley et al., 2002; Elsliger et al., 2010) 
Materials and methods

Protein production and crystallization
Clones were generated using the Polymerase Incomplete Primer Extension (PIPE) cloning method (Klock et al., 2008) . The gene encoding bfAPI (GenBank YP_209877, UniProt Q650A5) was amplified by polymerase chain reaction (PCR) from B. fragilis NCTC 9343 genomic DNA (ATCC No. 25285D) using Pfu Turbo DNA polymerase (Stratagene) and I-PIPE (Insert) primers (forward primer, 5 0 -ctgtacttccagggc ATGATTGAATCTATTCAAGAACTCCTGC-3 0 ; reverse primer, 5 0 -aattaagtcgcgttaCTTTACGCATAGTTTTCTTGA-TTTTTCG-3 0 ; target sequence in upper case) that included sequences for the predicted 5 0 and 3 0 ends. The expression vector pSpeedET, which encodes an amino-terminal Tobacco etch virus protease-cleavable expression and purification tag (MGSDKIHHHHHHENLYFQ/G), was PCR-amplified with V-PIPE (Vector) primers (forward primer, 5 0 -taacgcgacttaattaactcgtttaaacggtctccagc-3 0 ; reverse primer, 5 0 -gccctggaagtacaggttttcgtgatgatgatgatgatg-3 0 ). The V-PIPE and I-PIPE PCR products were mixed to anneal the amplified DNA fragments together. E. coli GeneHogs (Invitrogen) competent cells were transformed with the I-PIPE/V-PIPE mixture and dispensed onto selective LB-agar plates. Expression was performed in a selenomethionine-containing medium at 37 C. Selenomethionine was incorporated via inhibition of methionine biosynthesis (Van Duyne et al., 1993) . At the end of fermentation, lysozyme was added to the culture to a final concentration of 250 mg ml À1 and the cells were harvested and frozen. After one freeze-thaw cycle, the cells were homogenized and sonicated in lysis buffer [50 mM HEPES, 50 mM NaCl, 10 mM imidazole, 1 mM tris(2-carboxyethyl)phosphine-HCl (TCEP) pH 8.0] and the lysate was clarified by centrifugation at 32 500g for 30 min. The soluble fraction was passed over nickel-chelating resin (GE Healthcare) pre-equilibrated with lysis buffer, the resin was washed with wash buffer [50 mM HEPES, 300 mM NaCl, 40 mM imidazole, 10%(v/v) glycerol, 1 mM TCEP pH 8.0] and the protein was eluted with elution buffer [20 mM HEPES, 300 mM imidazole, 10%(v/v) glycerol, 1 mM TCEP pH 8.0]. The eluate was buffer-exchanged with HEPES crystallization buffer [20 mM HEPES, 200 mM NaCl, 40 mM imidazole, 1 mM TCEP pH 8.0] using a PD-10 column (GE Healthcare) and concentrated to 20 mg ml À1 using centrifugal ultrafiltration (Millipore). bfAPI was crystallized using the nanodroplet vapor-diffusion method (Santarsiero et al., 2002) with standard JCSG crystallization protocols (Lesley et al., 2002) . Sitting drops composed of 200 nl protein solution mixed with 200 nl crystallization solution were equilibrated against 50 ml reservoir solution at 277 K for 18 d prior to harvesting. The crystallization reagent consisted of 5% PEG 6000, 0.1 M MES pH 6.0. Ethylene glycol was added to a final concentration of 20%(v/v) as a cryoprotectant. The oligomeric state of bfAPI in solution was determined to be a tetramer using a 1 Â 30 cm Superdex 200 column (GE Healthcare) coupled with miniDAWN static light-scattering (SEC/SLS) and Optilab differential refractive-index detectors (Wyatt Technology). The mobile phase consisted of 20 mM Tris pH 8.0, 150 mM sodium chloride and 0.02%(w/v) sodium azide.
Data collection, structure solution and refinement
Multiple-wavelength anomalous diffraction (MAD) data were collected to 1.7 Å resolution on beamline 11-1 at SSRL at wavelengths corresponding to the inflection ( 1 ), highenergy remote ( 2 ) and peak ( 3 ) of a selenium MAD experiment. The data sets were collected at 100 K using a MAR Mosaic 325 CCD detector (Rayonix). The MAD data were integrated using MOSFLM (Leslie, 1992) and scaled with SCALA from the CCP4 suite (Winn et al., 2011 ). An initial substructure solution was obtained with SHELXD (Sheldrick, 2008) and the phases were refined using auto-SHARP (Vonrhein et al., 2007) , with a mean figure of merit of 0.50 with 28 selenium sites. Automated model building was performed with RESOLVE (Terwilliger, 2003) . Model building and refinement were performed with Coot (Emsley & Cowtan, 2004) and REFMAC5.5 (Winn et al., 2003) using the high-energy remote ( 2 ) data set. The refinement included NCS restraints, phase restraints from SHARP and TLS parameters with four TLS groups: one group per chain. Datacollection and refinement statistics are summarized in Table 1 .
Unaccounted-for electron density at the active site was observed in the experimental maps, and was later unambiguously assigned to CMP-Kdo during model building and refinement (Fig. 3d ). Since CMP-Kdo was not added at any stage of protein production, it must have originated from the expression system and remained bound throughout purification and crystallization.
Validation and deposition
The quality of the crystal structure was analyzed using the JCSG Quality Control server (http://smb.slac.stanford.edu/ jcsg/QC). This server verifies the stereochemical quality of the model using AutoDepInputTool (Yang et al., 2004) , MolProbity (Chen et al., 2010) and PHENIX (Adams et al., 2010) , the agreement between the atomic model and the data research papers using RESOLVE (Terwilliger, 2000) , the protein sequence using ClustalW (Thompson et al., 1994) , the ADP distribution using PHENIX and differences in R cryst /R free , expected R free / R cryst and various other items including atom occupancies, consistency of NCS pairs, ligand interactions, special positions etc. using in-house scripts to analyze the refinement log file and PDB header. Protein quaternary structure analysis was performed using the PISA server (Krissinel & Henrick, 2007) . Atomic coordinates and experimental structure factors have been deposited in the PDB as entry 3etn.
Results and discussion
Sequence similarity
A sequence similarity search with the bfAPI protein sequence using HMMER (Finn et al., 2011) against the NCBI nonredundant protein sequence database identified $2000 homologous protein sequences with E-values of <e À30 . These sequences were from several families of sugar phosphate isomerases, including KdsD, KpsF, GutQ and polysialic acid capsule expression protein. 95% of these sequences were multi-domain proteins containing an SIS domain and one or two CBS domains, and the rest were single-domain proteins containing an SIS domain only. Alignment of these top 2000 sequences revealed several highly conserved residues including Lys50, Ser64, His79, Asp81, Asp89, Ser95, Ser97, Gly98, Glu102, Glu145, Asp165 and His186 (Fig. 2 ). The alignment also shows that His187 and Tyr190 are only conserved in single-domain proteins which are mostly present in the genus Bacteroides.
API genes are abundant in the pathogenic Gram-negative bacteria within the Enterobacteriaceae family. A further sequence-similarity search with the bfAPI protein sequence using HMMER against the UniProtKB database limited to Enterobacteriaceae (taxid 543) found $5400 sequences with E-values of <e À6 , which were all annotated as either arabinose-5-phosphate isomerase, KdsD, GutQ or KpsF. 8437 organisms are listed in the Enterobacteriaceae family in UniProtKB; $93% of these Gram-negative bacteria are pathogenic and include Klebsiella pneumoniae, Yersinia pestis, Salmonella, Shigella and certain strains of E. coli. Overall, the 5400 sequences identified above represent $70% of the pathogenic Gram-negative bacteria in the Enterobacteriaceae family.
Overall structure
The final model consists of a tetramer (residues 0-191 for chains A and C and residues À4-193 for chains B and D), four CMP-Kdo, seven ethylene glycol and 725 water molecules in the asymmetric unit (Figs. 3a and 3b) . Parts of the N-terminal tag (À18 to À1 in chains A and C and À18 to À5 in chains B and D) and C-terminal residues (192-201 in chains A and C and 194-201 in chains B and D) were disordered. bfAPI is an / protein containing an SIS domain. It adopts a flavodoxinlike, three-layered // fold, in which the central fivestranded -sheet (2-1-3-4-5) is sandwiched between helices 4, 5, 6 and 7 on one side and 2, 3 and 8 on the other side (Fig. 3c) . In addition, bfAPI has a long helix 1 (residues 1-17) at the N-terminus and helix 9 (residues 188-192) at the C-terminus. bfAPI was determined to be a tetramer in solution by size-exclusion chromatography, which is consistent with the oligomerization state in the crystal lattice and the reported oligomerization states of other characterized API enzymes (Gourlay et al., 2010; Meredith & Woodard, 2005 , 2006 (Weiss & Hilgenfeld, 1997) . } R cryst = P hkl jF obs j À jF calc j = P hkl jF obs j, where F calc and F obs are the calculated and observed structure-factor amplitudes, respectively. † † R free is calculated as for R cryst but for 5.0% of the total reflections chosen at random and omitted from refinement. ‡ ‡ This value represents the total B that includes TLS and residual B components. § § The percentage of residues in Ramachandran favored and outlier regions and the percentage of poor rotamers were calculated using MolProbity. ). Interactions between dimer 1 and dimer 2 are formed from helices 1, 3 and 8 of one subunit, which make extensive hydrogen-bonding interactions with their counterparts 1 0 , 3 0 and 8 0 from the other subunit. A hydrogen bond between Lys50 from 3 of one subunit and Asp165 from 8 0 of the other subunit helps to anchor the C-terminal 9 helix that contains the active-site residue His186.
The active site
As the four copies of the active site in the asymmetric unit are nearly identical, only the active site in subunit A will be described. The active site is located in a cleft at the tetramer interface that is composed of residues from loops L 1-3 and L 3-6 of subunit A, 9 and the C-terminal tail of subunit B and the region around 4 and 5 of subunit C. Loop L 3-6 contains a Ser/Thr-rich region with the highly conserved residues Ser95 and Ser97 forming hydrogen bonds to the phosphate group of the bound CMP-Kdo molecule. In all four active sites CMP-Kdo molecules are bound on the C-terminal side of the central -sheet, with the 3-deoxy-d-manno-oct-2-ulosonate group pointing towards the central -sheet and His79 in helix 4 is an invariant residue among API sequences and is equivalent to His88 in E. coli API/KdsD (ecAPI; PDB entry 2xhz), where biochemical and mutational experiments have confirmed its catalytic role (Gourlay et al., 2010) . His79 is located near the phosphate O atoms and the C4 and C5 hydroxyl groups of the bound Kdo. The C4 atom of Kdo is derived from the C1 atom of A5P during CMP-Kdo biosynthesis. The N 1 atom of His79(C) hydrogen bonds to the Tyr190(B) hydroxyl, which is further hydrogen-bonded to the Kdo C5 hydroxyl. Tyr190(B) is located between the Kdo moiety and His186(B) and therefore blocks any direct interaction between His186(B) and CMP-Kdo.
Interestingly, the bound CMP-Kdo molecule in the active site is neither a product nor a substrate of bfAPI and is not derived from the crystallization solution. It is the end product of the reaction catalyzed by KdsB in the last step of Kdo biosynthesis. However, the primary sequences of bfAPI and KdsB are unrelated and their structures are completely different, while the known KdsB structures (E. coli, PDB entry 3k8d, Heyes et al., 2009 ; Acinetobacter baumannii, PDB entry 3pol, Center for Structural Genomics of Infectious Diseases, unpublished work; Yersinia pestis, PDB entry 3jtj, Center for Structural Genomics of Infectious Diseases, unpublished work; Haemophilus influenzae, PDB entry 1vh3, Badger et al., 2005 ; Vibrio cholerae, PDB entry 3oam, Center for Structural Genomics of Infectious Diseases, unpublished work) share significant sequence and structure similarities.
Since an end product of a biosynthetic pathway often inhibits the first or early steps of the reaction pathway (Pardee, 1971) , our observations suggest that the bound CMP-Kdo observed in our bfAPI structure may act as a feedback inhibitor of bfAPI. Our hypotheses are supported by recent studies that demonstrate that CMP-Kdo does effectively inhibit bfAPI (K i = 1.91 mM; Cech et al., 2014) and raises the possibility of using the natural inhibitor CMP-Kdo as a lead compound for drug discovery. An analogous study has been reported in which hydroxamates were used as enediol mimics to probe for potent inhibitors of Francisella tularensis KdsD . In that study, 4-phospho-2,3-acetyl-d-erythrose hydroxamate (PDB entry 4peh; Fig. 1b) with an IC 50 of 7 mm (approximate K i of 1.93 mM calculated using the BotDB web server; Cer et al., 2009) was the most potent inhibitor among those tested. The bfAPI and F. tularensis KdsDs share 40% sequence identity and the key active-site residues His79 and His186 are conserved.
Structure-similarity analyses
Other than bfAPI, E. coli API (ecAPI; PDB entry 2xhz) is the only other API structure available (Gourlay et al., 2010) . Although ecAPI is a multi-domain API containing an SIS domain and a pair of CBS domains, the protein construct used to determine the crystal structure only contains residues 1-183 corresponding to the SIS domain. The biological assembly of ecAPI is also a tetramer like bfAPI. Superimposition of ecAPI onto bfAPI results in an r.m.s.d. of 1.2 Å for 167 aligned C atoms. The overall structures and active sites align well and the sequence-conserved residues His79, Ser95, Ser97, Thr100, Glu102, Glu145 and Asp165 are all structurally conserved. Comparison of API and SPI structures. (a) Superimposition of the bfAPI structure (gray) onto KdsD from E. coli K-12 MG1655 (ecAPI; PDB entry 2xhz; yellow), the putative sugar-phosphate isomerase from L. monocytogenes strain 4b (lmSPI; PDB entry 3fxa; blue) and 3-hexulose-6-phosphate isomerase from M. jannaschii (mjPHI; PDB entry 1jeo; orange). CMP-Kdo in bfAPI is shown in a green ball-and-stick representation. (b) Comparison of the active sites in the bfAPI, ecAPI, lmSPI and mjPHI structures. His79, His186, Tyr190 and CMP-Kdo in bfAPI are shown in green ball-and-stick representation. The dual conformers of His188 in lmSPI subunit D are shown in blue and His176 of mjPHI is shown in an orange ball-and-stick representation. The histidine residues from ecAPI and ImSPI that are equivalent to His79 of bfAPI are shown in yellow and blue ball-and-stick representations, respectively. Residue names are labeled in green, blue and red for bfAPI, lmSPI and mjPHI, respectively.
A putative sugar-phosphate isomerase from Listeria monocytogenes strain 4b (lmSPI; PDB entry 3fxa; r.m.s.d. of 1.4 Å for 181 aligned C atoms; Joint Center for Structural Genomics, unpublished work) and 3-hexulose-6-phosphate isomerase from Methanococcus jannaschii (mjPHI; PDB entry 1jeo; r.m.s.d. of 1.9 Å for 156 aligned C atoms; Martinez-Cruz et al., 2002) are the other identified top hits from a PDBeFold structure-similarity search (Krissinel & Henrick, 2007) . lmSPI and mjPHI are both single-domain SIS-containing proteins and share sequence identities of 35% (52% similarity) and 26% (46% similarity) to bfAPI, respectively. The mjPHI structure contains a citric acid molecule bound near the equivalent Kdo binding site in bfAPI, but lmSPI does not have any bound ligand. When all four structures are superimposed (Fig. 4a) , we observe that His186 of bfAPI is structurally equivalent to His188 of lmSPI and His176 of mjPHI (Fig. 4b) . The equivalent residue (His193) in ecAPI is not present in the structure since this region was not included in the construct used for structure determination. ecAPI and lmSPI have a histidine residue at the position equivalent to His79 of bfAPI which is not conserved in mjPHI (Fig. 4b) . His188 from lmSPI subunit D adopts two alternate side-chain conformations. The His imidazole in the first conformation points away from the active site and is observed in all subunits of lmSPI and bfAPI, whereas in the second conformation it points towards the active site in subunit D of lmSPI and in the mjPHI structures.
If His186 of bfAPI were to adopt this second conformation, it would clash with the side chain of Tyr190. Interestingly, mutation of the equivalent residue in ecAPI, His193, to alanine yields an enzyme that is inactive both in vivo and in vitro (Gourlay et al., 2010) . Previous structural and sequence analyses of mjPHI have also shown that His176 has a catalytic role (Martinez-Cruz et al., 2002) . Based on the observations above, we speculate that His186 may play an important catalytic role in bfAPI. The fact that the His186 imidazole points away from the bound CMP-Kdo molecule could stem from the orientation of the Tyr190 side chain in this structure (Fig. 4b) . Tyr190 is strictly conserved among single-domain APIs but not in multi-domain APIs. It is located in the flexible C-terminal tail region and could presumably function as a gate where it would move close to the bound inhibitor to block enzyme activity and move away when the actual substrate is bound to allow the approach of the catalytic His186 for enzyme activity. Therefore, Tyr190 could play a regulatory role for bfAPI activity, which is presumably carried out by the CBS domain in multi-domain API enzymes. Comparison of API and PGI structures. (a) Superposition of the bfAPI and rabbit PGI-5PAA (PDB entry 1g98) structures. 1g98 is shown in gray ribbons and the bfAPI monomers superimposed onto the small and large SIS domains of 1g98 are shown as green and yellow ribbons, respectively. CMP-Kdo from the bfAPI structure and 5PAA from the 1g98 structure are shown in ball-and-stick representation. 5PAA was only bound in the small domain of 1g98. (b) Comparison of the bfAPI and the small domains of the PGI structures shows that His79 and the Ser/Thr-rich region are structurally conserved and Ser64 of bfAPI corresponds to a conserved glutamate in PGI. The phosphate group of each of the bound ligand in the PGI structures interacts with the Ser/Thr-rich loop and overlaps with the carboxylate group in Kdo. bfAPI is shown as green ribbons and the PGIs are shown as gray ribbons. The ligands are shown in ball-and-stick representation with N atoms in blue, O atoms in red, P atoms in orange and C atoms of CMP-Kdo and PGIs in cyan and yellow, respectively. The carbon atoms of the active-site residues in bfAPI and PGIs are colored cyan and yellow, respectively. The PDB code, the substrate/product analogs (in parentheses) and the source organisms of the PGI structures used in the superimposition are 2cxp (A5P), mouse; 1u0f (G6P, glucose 6-phosphate), mouse; 1hox (F6P, fructose 6-phosphate), rabbit; 1g98 (5PAA, 5-phospho-d-arabinonate), rabbit; 1nuh (5PAA), human; 1gzv (5PAA), Sus scrofa; 2o2c (G6P), Trypanosoma brucei; 2q8n, Thermotoga maritima. Note that for clarity only eight of the 16 PGI structures mentioned in x3.5 are shown.
known about the catalytic mechanism of API and the catalytic residues involved, we gleaned some insights by comparing bfAPI with other sugar isomerases, such as phosphoglucose isomerase (PGI), which catalyze an analogous reaction with similar substrates. PGI, a key enzyme in glycolysis, is a sugar isomerase that catalyzes the reversible isomerization of Comparison of bfAPI with mouse PGI-A5P (PDB entry 2cxp), rabbit PGI-F6P (PDB entry 1hox) and mjPHI structures suggests a catalytic role for His79 and His186. The structures of bfAPI, 2cxp, 1hox and mjPHI are shown in ribbon representation and are colored blue, yellow, orange and gray, respectively. CMP-Kdo from bfAPI, A5P from 2cxp, F6P from 1hox and the active-site residues are shown in ball-and-stick representation with N atoms in blue, O atoms in red and P atoms in orange. The C atoms of CMP-Kdo and the activesite residues of bfAPI are in green, while the C atoms of A5P and the active-site residues of 2cxp are in yellow, the C atoms of F6P and the active-site residues of 1hox are in orange and the C atoms of His176 from mjPHI are in gray. Residue names of bfAPI, 2cxp, 1hox and mjPHI are labeled in black, blue, green and red, respectively. glucose 6-phosphate to fructose 6-phosphate. To date, 59 structures of bacterial and eukaryotic PGIs are available in the Protein Data Bank, 52 of which have ligands bound at their active site. These PGIs range in size from 450 to 600 residues. However, all have similar structures, with differences mostly observed at the N-and C-termini and in the loop regions. PGI is active as a dimer and the active site is located at the dimer interface. Each PGI subunit consists of two SIS domains conventionally named the large domain (residues 1-98 and 294-514) and the small domain (residues 99-293), both of which share structural similarity to bfAPI. A superimposition of bfAPI onto the large and the small domains of rabbit PGI-5PAA (PDB entry 1g98; Jeffery et al., 2001 ) results in an r.m.s.d. of 2.9 Å for 168 C atoms for the large domain and an r.m.s.d. of 2.4 Å for 132 C atoms for the small domain (Fig. 5a ). The active-site structure of API is more similar to that of the rabbit PGI small domain. When a bfAPI subunit is superimposed onto the large and small domains of rabbit PGI separately, the Ser/Thr-rich loop in bfAPI superimposes well with the equivalent loop from the small domain of rabbit PGI, whereas the equivalent loop in the large domain is much longer. This longer loop extends through the space that is occupied by the Ser/Thr-rich loop and the CMP-Kdo molecule in bfAPI; therefore, it would block access of substrates to this site and thus prevent it from becoming an active site. Furthermore, the highly conserved histidine residue (His388 from a neighboring subunit in rabbit PGI-5PAA; PDB entry 1g98) that has been proposed to be responsible for sugar ring opening in PGI is only present in the active site of the small domain and not in that of the large domain. Therefore, PGI only has two active sites per dimer, despite it being comprised of four SIS domains as in API, which has four active sites.
Since both bfAPI and PGI catalyze isomerization reactions with similar phosphosugar substrates (a five-carbon versus a six-carbon phosphosugar), their active sites are expected to share some structural similarities for substrate binding and catalysis; however, each must possess unique features that define substrate specificity. For comparison of the active sites, a total of 16 PGI structures were selected from the PDB and structures containing ligands similar to A5P or Ru5P were preferably selected. The source organisms, the bound substrate/product analogues and the PDB codes of these PGI proteins are as follows: Mus musculus, A5P, 2cxp; M. musculus, glucose 6-phosphate (G6P, ring form), 1u0f; Oryctolagus cuniculus (rabbit), fructose 6-phosphate (F6P, ring form), 1hox; O. cuniculus, 5-phosphoarabinonate (5PAA; Fig. 1b ), 1g98; Sus scrofa, 5PAA, 1gzv; Homo sapiens, 5PAA, 1nuh; Leishmania mexicana, F6P, 1t10; Pyrobaculum aerophilum, G6P, 1x9i; Trypanosoma brucei, G6P, 2o2c; Francisella tularensis subsp., F6P (ring form), 3m5p; F. tularensis subsp., 6-phosphogluconate (6PGA), 3q7i; Thermotoga maritima, 2q8n; Mycobacterium tuberculosis, 2wu8; Staphylococcus aureus subsp., 3ff1; Vibrio cholerae, 3hjb; Bacillus anthracis, 3ifs. All bound sugar substrate/product analogues are in the open-chain conformation if not otherwise specified and the last five structures do not contain any substrate/product analogues. With the exception of 8 and the C-terminal tail, the bfAPI structure superimposes well with the small domains of these PGIs. The active site, including the Ser/Thr-rich region and His79, is structurally conserved (Fig. 5b) . In PGI, the conserved histidine residue in the active site that is equivalent to His79 of bfAPI also comes from a neighboring subunit. The phosphosugar ligands in these PGI structures all have similar binding modes, with the phosphate groups interacting with the Ser/Thr-rich region (phosphate-binding loop). In bfAPI, the phosphate moiety of CMP-Kdo also interacts with the Ser/Thr-rich region. The consensus sequence of this Ser/Thr-rich region among PGIs and APIs is S-X-S/T-X-X-S/T.
Previous studies of the rabbit PGI enzyme identified the key catalytic residues His388, Glu357, Lys518 and Arg272 Lee et al., 2001) . His388 catalyzes the ringopening step and Glu357 is the general acid/base catalyst for the isomerization reaction; the reaction proceeds through a cis-enediol intermediate. Both His388 and Glu357 are highly conserved in PGI. His388 is structurally equivalent to His79 of bfAPI, but Glu357 does not have a structural equivalent in bfAPI; the equivalent residue is Ser64 and this serine is strictly conserved among APIs. Glutamate has a favorable pK a for functioning as a general acid/base and the longer side chain of glutamate can easily access the C1 and C2 atoms of the bound phosphosugar ligand for catalysis. On the other hand, serine, with a side-chain pK a of $13, is not a good candidate for general acid/base catalysis. Arg272 and Lys518 of rabbit PGI are absent in bfAPI, which is expected since these residues are located in the C-terminal region that differs significantly between bfAPI and rabbit PGI. These structural differences are likely to contribute to the differences in substrate specificity between API and PGI. PGI is specific for G6P and F6P, whereas API is specific for Ru5P and A5P and cannot utilize similar molecules such as d-ribose 5-phosphate, d-arabinose, d-glucose, d-glucose 6-phosphate, d-mannose 6-phosphate or d-glucosamine 6-phosphate (Meredith & Woodard, 2003 , 2006 .
If API does not use a glutamate as a general acid/base for catalysis, what residue could act in this role? Of the 16 PGI structures compared here, two contain ligands most relevant to API. PGI from M. musculus (PDB entry 2cxp) has a bound A5P in its open-chain form and rabbit PGI (PDB entry 1hox) has an F6P bound in its ring form. The active-site structures and key residues in bfAPI, 2cxp and 1hox superimpose well (Figs. 6e and 6f) . Because of these similarities, once could postulate that the substrate-binding mode in bfAPI is similar. If A5P adopts the same binding mode in both 2cxp and bfAPI, C1 and C2 of A5P would be located close to His186 if His186 were to adopt a side-chain conformation similar to His176 of mjPHI, which points towards A5P (Fig. 6g) . His186 is therefore a potential candidate for a general acid/base catalyst. This hypothesis is supported by several observations. Firstly, His186 is highly conserved among APIs and is structurally equivalent to His193 of ecAPI (Gourlay et al., 2010) and His176 of mjPHI (Martinez-Cruz et al., 2002) , which are both critical in catalysis. Furthermore, biochemical studies have shown that the activity of APIs is inhibited by the divalent ions research papers
